ImpriMed

Mountain View, United States

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

$23.0M raised

Nov 2023

Series A

Top Investors

Plug and PlayPear VCDraper AssociatesSBVAMayo Clinic

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ImpriMed raised?

ImpriMed has raised $23.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.

Who are ImpriMed's investors?

ImpriMed's investors include Plug and Play, Pear VC, Draper Associates, SBVA, Mayo Clinic.

Where is ImpriMed headquartered?

ImpriMed is headquartered in Mountain View, United States.

What does ImpriMed do?

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

What stage is ImpriMed at?

ImpriMed is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 6, 2023.

MLA

"ImpriMed — Funding & Investors." VCBacked, November 6, 2023, https://www.vcbacked.co/company/imprimed. Accessed June 4, 2026.

APA

VCBacked. (2023). ImpriMed — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/imprimed

Wikipedia (cite web)

{{cite web |title=ImpriMed — Funding & Investors |url=https://www.vcbacked.co/company/imprimed |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 6, 2023.